Catalyst Pharmaceuticals, Inc. (CPRX) NASDAQ
24.69
-0.13(-0.52%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
24.69
-0.13(-0.52%)
Currency In USD
| Market Cap | 2.85B |
| Enterprise Value | 2.15B |
| P/E Ratio | 14.09 |
| PEG Ratio | -5.07 |
| Price/Sales Ratio | 5.15 |
| Price/Book Ratio | 3.16 |
| Enterprise/Revenue | 3.95 |
| Enterprise/EBITDA | 7.44 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.36 |
| Operating Margin | 0.44 |
| Return On Assets | 0.19 |
| Return On Equity | 0.24 |
| Revenue | 588.99M |
| Revenue/Share | 4.82 |
| Gross Profit | 501.74M |
| EBITDA | 321.01M |
| Net Income | 214.33M |
| Diluted EPS | 1.68 |
| Total Cash | 709.17M |
| Total Cash/Share | 5.8 |
| Total Debt | 2.79M |
| Total Debt/Equity | 0 |
| Current Ratio | 6.08 |
| Book Value Per Share | 7.8 |
| 52-Week Change | 0.94 |
| 52-Week High | 26.58 |
| 52-Week Low | 19.05 |
| Moving Average 50 Days | 24.07 |
| Moving Average 200 Days | 22.22 |
| Average Volume | 1.24M |
| Shares Outstanding | 122.91M |
| % Held by Institutions | 84.79 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |